Top Markets
#1 Zora Zora +31.09%
#2 Tutorial Tutorial +28.83%
#3 GALA GALA +25.38%
#4 Fabric Protocol Fabric Protocol +24.31%
#5 Pieverse Pieverse +23.14%
#6 Arowana Arowana +22.11%
#7 Derive Derive +21.73%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +20.51%
#9 Bitcoin Cash Bitcoin Cash +20.00%
#10 wojak wojak +19.94%
Coin of the day
Zora Zora
Settings
Language
ENGLISH
Currency
USD
Theme
SomnoMed Limited SomnoMed Limited

SomnoMed Limited

SOM
Rank in Stocks #24938
SomnoMed Limited, together with its subsidiaries, produce and sells devices for... SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Share Price
$0.2503761
Market Cap
$55.02M
Change (1 day)
-2.74%
Change (1 year)
-45.86%
Country
AU
Trade SomnoMed Limited (SOM)

Category

Healthcare
Revenue for SomnoMed Limited (SOM)
Revenue in Aug 2026 TTM: 0
According to SomnoMed Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for SomnoMed Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE